Latest news

Become a Distributor

Andy Boyes appointed as Non-Executive Director to Synapse Electroceutical Limited

Synapse Electroceutical Limited is delighted to announce the appointment of Andy Boyes to the Board. Andy has enjoyed a successful, 32 year career at Smith & Nephew, the FTSE 100 medical technology business engaged in developing, manufacturing, marketing and selling medical devices in the Advanced Wound Management and Advanced Surgical Devices sectors with sales in excess of £4 billion. Andy is passionate
about the wound care sector and helping improve the lives of patients suffering with debilitating complex wounds and since leaving Smith & Nephew has focussed on providing Board level support and strategic direction in the sector.

Read this article

'Electrical stimulation therapy and electroceutical treatment for the management of venous leg ulcers’ published in Community Wound Care

The use of innovative technologies for transforming and improving clinical outcomes and reducing costs in the NHS was an integral component of the NHS Five Year Forward View (2014). The use of electroceutical treatment has been demonstrated to both improve patient outcomes and reduce costs to the NHS for the management of chronic wounds.

Read this article

'Using electroceutical treatment to reduce symptoms and improve healing in chronic wounds’ published in Primary Health Care

Use of electroceutical treatment effectively restores the current of injury, expediting normal healing and reducing chronic inflammation, biofilms, infection and associated symptoms, such as pain and high exudate. Clinical outcomes and QoL are improved and there are also economic benefits.

Read this article

Other articles

Information for Clinicians

Accel-Heal product shot